ArticleNeurology2022

Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells.

Philipp Karschnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.